Skip to menu Skip to content Skip to footer

2019

Journal Article

Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledge

Rajagopalan, Arvind, Sathananthan, Dharshan, An, Yoon‐Kyo, Van De Ven, Lucinda, Martin, Serena, Fon, James, Costello, Samuel P, Begun, Jakob and Bryant, Robert V (2019). Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledge. JGH Open, 4 (2) jgh3.12268, 267-272. doi: 10.1002/jgh3.12268

Gastrointestinal ultrasound in inflammatory bowel disease care: patient perceptions and impact on disease‐related knowledge

2019

Journal Article

Distinct tissue-specific roles for the disease-associated autophagy genes ATG16L2 and ATG16L1

Khor, Bernard, Conway, Kara L., Omar, Abdifatah S., Biton, Moshe, Haber, Adam L., Rogel, Noga, Baxt, Leigh A., Begun, Jakob, Kuballa, Petric, Gagnon, John D., Lassen, Kara G., Regev, Aviv and Xavier, Ramnik J. (2019). Distinct tissue-specific roles for the disease-associated autophagy genes ATG16L2 and ATG16L1. The Journal of Immunology, 203 (7), ji1800419-1829. doi: 10.4049/jimmunol.1800419

Distinct tissue-specific roles for the disease-associated autophagy genes ATG16L2 and ATG16L1

2019

Journal Article

MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity

Sheng, Yong Hua, Wong, Kuan Yau, Seim, Inge, Wang, Ran, He, Yaowu, Wu, Andy, Patrick, Maya, Lourie, Rohan, Schreiber, Veronika, Giri, Rabina, Ng, Choa Ping, Popat, Amirali, Hooper, John, Kijanka, Gregor, Florin, Timothy H., Begun, Jakob, Radford, Kristen J., Hasnain, Sumaira and McGuckin, Michael A. (2019). MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity. Oncogene, 38 (48), 7294-7310. doi: 10.1038/s41388-019-0951-y

MUC13 promotes the development of colitis-associated colorectal tumors via β-catenin activity

2019

Journal Article

Mindfulness based cognitive therapy experiences in youth with inflammatory bowel disease and depression: protocol for a mixed methods qualitative study

Ewais, Tatjana, Begun, Jake, Kenny, Maura, Headey, Alan and Kisely, Steve (2019). Mindfulness based cognitive therapy experiences in youth with inflammatory bowel disease and depression: protocol for a mixed methods qualitative study. JMIR Research Protocols, 8 (7) e14432, e14432. doi: 10.2196/14432

Mindfulness based cognitive therapy experiences in youth with inflammatory bowel disease and depression: protocol for a mixed methods qualitative study

2019

Journal Article

Clinical decision support improves quality of care in patients with ulcerative colitis

Jackson, Belinda, Begun, Jake, Gray, Kathleen, Churilov, Leonid, Liew, Danny, Knowles, Simon and De Cruz, Peter (2019). Clinical decision support improves quality of care in patients with ulcerative colitis. Alimentary Pharmacology and Therapeutics, 49 (8), 1040-1051. doi: 10.1111/apt.15209

Clinical decision support improves quality of care in patients with ulcerative colitis

2019

Journal Article

Protocol for a pilot randomised controlled trial of mindfulness-based cognitive therapy in youth with inflammatory bowel disease and depression

Ewais, Tatjana, Begun, Jake, Kenny, Maura, Chuang, Kai-Hsiang, Barclay, Johanna, Hay, Karen and Kisely, Steve (2019). Protocol for a pilot randomised controlled trial of mindfulness-based cognitive therapy in youth with inflammatory bowel disease and depression. BMJ Open, 9 (4) e025568, e025568. doi: 10.1136/bmjopen-2018-025568

Protocol for a pilot randomised controlled trial of mindfulness-based cognitive therapy in youth with inflammatory bowel disease and depression

2019

Journal Article

Interleukin-22: friend or foe?

Hasnain, Sumaira Z. and Begun, Jakob (2019). Interleukin-22: friend or foe?. Immunology and Cell Biology, 97 (4), 355-357. doi: 10.1111/imcb.12249

Interleukin-22: friend or foe?

2019

Journal Article

A systematic review and meta-analysis of mindfulness based interventions and yoga in inflammatory bowel disease

Ewais, Tatjana, Begun, Jake, Kenny, Maura, Rickett, Kirsty, Hay, Karen, Ajilchi, Bita and Kisely, Steve (2019). A systematic review and meta-analysis of mindfulness based interventions and yoga in inflammatory bowel disease. Journal of Psychosomatic Research, 116, 44-53. doi: 10.1016/j.jpsychores.2018.11.010

A systematic review and meta-analysis of mindfulness based interventions and yoga in inflammatory bowel disease

2018

Journal Article

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

Flanagan, Emma, Gibson, Peter R., Begun, Jakob, Ghaly, Simon, Garg, Mayur, Andrews, Jane M., Rosella, Ourania, Rosella, Gennaro and Bell, Sally J. (2018). Letter: vedolizumab drug concentrations in neonates following intrauterine exposure. Alimentary Pharmacology and Therapeutics, 48 (11-12), 1328-1330. doi: 10.1111/apt.15027

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure

2018

Journal Article

Personalizing inflammatory bowel disease treatment symposium: Foreward

Begun, Jakob (2018). Personalizing inflammatory bowel disease treatment symposium: Foreward. Journal of Gastroenterology and Hepatology, 33 (S3), 3-3. doi: 10.1111/jgh.14414

Personalizing inflammatory bowel disease treatment symposium: Foreward

2018

Journal Article

The role of IL-22 in the resolution of sterile and nonsterile inflammation

Alabbas, Saleh Y, Begun, Jakob, Florin, Timothy H and Oancea, Iulia (2018). The role of IL-22 in the resolution of sterile and nonsterile inflammation. Clinical and Translational Immunology, 7 (4) e1017, e1017. doi: 10.1002/cti2.1017

The role of IL-22 in the resolution of sterile and nonsterile inflammation

2018

Journal Article

Enterococcus faecalis AHG0090 is a genetically tractable bacterium and produces a secreted peptidic bioactive that suppresses nuclear factor Kappa B activation in human gut epithelial cells

Ó Cuív, Páraic, Giri, Rabina, Hoedt, Emily C., McGuckin, Michael A., Begun, Jakob and Morrison, Mark (2018). Enterococcus faecalis AHG0090 is a genetically tractable bacterium and produces a secreted peptidic bioactive that suppresses nuclear factor Kappa B activation in human gut epithelial cells. Frontiers in Immunology, 9 (April) 790, 790. doi: 10.3389/fimmu.2018.00790

Enterococcus faecalis AHG0090 is a genetically tractable bacterium and produces a secreted peptidic bioactive that suppresses nuclear factor Kappa B activation in human gut epithelial cells

2018

Journal Article

Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application

Bryant, Robert Venning, Friedman, Antony, Wright, Emily Kate, Taylor, Kirstin, Begun, Jakob, Maconi, Giovanni, Maaser, Christian, Novak, Kerri L., Kucharzik, Torsten, Atkinson, Nathan S. S., Asthana, Anil and Gibson, Peter R. (2018). Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut, 67 (5), 973-985. doi: 10.1136/gutjnl-2017-315655

Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application

2017

Journal Article

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases

Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., Barclay, M., Begun, J., Bryant, R., Chan, W., Corte, C., Ghaly, S., Lemberg, D. A., Kariyawasam, V., Lewindon, P., Martin, J., Mountifield, R., Radford-Smith, G., Slobodian, P., Sparrow, M., Toong, C., van Langenberg, D., Ward, M. G. and Leong, R. W. (2017). Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology & Therapeutics, 46 (11-12), 1037-1053. doi: 10.1111/apt.14368

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases

2017

Journal Article

Colonic thioguanine pro-drug: investigation of microbiome and novel host metabolism

Florin, Timothy, Movva, Ramya, Begun, Jakob, Duley, John, Oancea, Iulia and O Cuiv, Paraic (2017). Colonic thioguanine pro-drug: investigation of microbiome and novel host metabolism. Gut Microbes, 9 (2), 1-4. doi: 10.1080/19490976.2017.1387343

Colonic thioguanine pro-drug: investigation of microbiome and novel host metabolism

2017

Journal Article

The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner

Cuív, Páraic Ó., de Wouters, Tomas, Giri, Rabina, Mondot, Stanislas, Smith, Wendy J., Blottière, Hervé M., Begun, Jakob and Morrison, Mark (2017). The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner. Anaerobe, 47, 209-217. doi: 10.1016/j.anaerobe.2017.06.002

The gut bacterium and pathobiont Bacteroides vulgatus activates NF-κB in a human gut epithelial cell line in a strain and growth phase dependent manner

2017

Journal Article

Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles

Tyagi, Nisha, De, Ranjit, Begun, Jakob and Popat, Amirali (2017). Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles. International Journal of Pharmaceutics, 518 (1-2), 220-227. doi: 10.1016/j.ijpharm.2016.12.030

Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles

2016

Journal Article

The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis

Elshaer, Dana and Begun, Jakob (2016). The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis. Seminars in Cell and Developmental Biology, 61, 51-59. doi: 10.1016/j.semcdb.2016.08.018

The role of barrier function, autophagy, and cytokines in maintaining intestinal homeostasis

2016

Journal Article

Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism

Oancea, I., Movva, R., Das, I., Aguirre de Carcer, D., Schreiber, V., Yang, Y., Purdon, A., Harrington, B., Proctor, M., Wang, R., Sheng, Y., Lobb, M., Lourie, R., Cuiv, P.O., Duley, J.A., Begun, J. and Florin, T.H.J. (2016). Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism. Gut, 66 (1), 59-69. doi: 10.1136/gutjnl-2015-310874

Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism

2016

Journal Article

High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22

Gulhane, Max, Murray, Lydia, Lourie, Rohan, Tong, Hui, Sheng, Yong H., Wang, Ran, Kang, Alicia, Schreiber, Veronika, Wong, Kuan Yau, Magor, Graham, Denman, Stuart, Begun, Jakob, Florin, Timothy H., Perkins, Andrew, Cuiv, Paraic O., McGuckin, Michael A. and Hasnain, Sumaira Z. (2016). High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22. Scientific Reports, 6 (1) 28990, 28990. doi: 10.1038/srep28990

High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22